MedPath

Rachel Jones

🇩🇯Djibouti
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Rituximab and Belimumab Combination Therapy in PR3 Vasculitis

Phase 2
Conditions
ANCA Associated Vasculitis
Granulomatosis With Polyangiitis
Interventions
First Posted Date
2019-05-30
Last Posted Date
2022-03-08
Lead Sponsor
Rachel Jones
Target Recruit Count
31
Registration Number
NCT03967925
Locations
🇬🇧

Addenbrooke's Hospital, Cambridge, United Kingdom

🇬🇧

Glasgow Royal Infirmary, Glasgow, United Kingdom

🇬🇧

Imperial College London, London, United Kingdom

and more 3 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.